|
Match
|
Document |
Document Title |
|
|
US20090258856 |
IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
The present invention relates to substituted imidazo-pyridinones and imidazo-pyridazinones of general formula
wherein Y and R 1 to R 4 are defined as in claim 1 , the tautomers, enantiomers,...
|
|
|
US20090215757 |
Process for Preparation of High-Purity Meloxicam and Meloxicam Potassium Salt
The invention provides a process for the preparation of high purity meloxicam of the Formula (II). The meloxicam raw product is reacted with the solution of potassium hydroxide or potassium...
|
|
|
US20090203680 |
In vivo studies of crystalline forms of meloxicam
The invention is directed to novel crystalline forms of meloxicam. These novel crystalline forms of meloxicam have improved bioavailability, an enhanced rate of dissolution and shorter time to C...
|
|
|
US20090163707 |
Process for the Purification of Meloxicam
A process for purifying meloxicam form I from a crude meloxicam, which comprises:
i. contacting the crude meloxicam with an amine in a non-aqueous solvent to form a meloxicam salt; ii....
|
|
|
US20090143368 |
Use of Cinnamoyl Compound
A composition for inhibiting the extracellular matrix gene transcription comprising a cinnamoyl compound represented by the formula (I):
and an inert carrier, or the like.
|
|
|
US20090017003 |
THIOSULFONATE ANTI-INFLAMMATORY AGENTS
The present invention relates to novel thiosulfonates derivatives. The present invention also provides methods for preventing, treating and/or reducing inflammation-associated diseases in the...
|
|
|
US20080188467 |
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and...
|
|
|
US20080171737 |
CYCLIC SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE
The present invention is directed to cyclic sulfonamide derivatives of formula I:
or a pharmaceutically acceptable salt thereof, which are monoamine reuptake inhibitors, compositions containing...
|
|
|
US20080119647 |
Process for the Purification of Meloxicam
A process for purifying meloxicam form I from a crude meloxicam, which comprises:
i. contacting the crude meloxicam with an amine in a non-aqueous solvent to form a meloxicam salt; ii....
|
|
|
US20080045513 |
COMBINATION FAAH INHIBITOR AND ANALGESIC, ANTI-INFLAMMATORY OR ANTI-PYRETIC AGENT
Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH...
|